SAFELY

Study Type: Observational [Patient Registry] Study Design:
  • Observational Model: Cohort
  • Time Perspective: Prospective
  • Estimated Enrollment: 600 participants
  • Target Follow-Up Duration: 10 Years
  • Official Title: A Multi-center, Prospective Active Surveillance Registry Trial Assessing the Performance of a Non-invasive Immunogenomic Blood Test for Indolent Prostate Cancer Disease Management.